Company Filing History:
Years Active: 2019
Title: Guenther Lametschwandtner: Innovator in Pharmaceutical Chemistry
Introduction
Guenther Lametschwandtner is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for medical applications. His work focuses on innovative solutions for treating neoplastic and infectious diseases.
Latest Patents
One of his key patents is titled "Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases." This invention relates to bicyclic tetrahydrothiazepine of formula (I), where R, X, and R have specific meanings as indicated in the description and claims. The patent also covers pharmaceutical compositions that include these compounds and their use as medicaments, especially in methods for treating or preventing neoplastic and infectious diseases.
Career Highlights
Throughout his career, Guenther has worked with several prominent companies in the pharmaceutical industry. Notable among these are Apeiron Biologics AG and Evotec SE. His experience in these organizations has allowed him to contribute to various innovative projects and advancements in drug development.
Collaborations
Guenther has collaborated with several professionals in his field, including Monika Ermann and Patricia Leonie Amouzegh. These collaborations have further enriched his research and development efforts.
Conclusion
Guenther Lametschwandtner is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of serious diseases. His innovative patents and collaborations highlight his commitment to advancing medical science.